DE69737101D1 - Zusammensetzungen zur gentransfer in das zentrale nervensystem - Google Patents

Zusammensetzungen zur gentransfer in das zentrale nervensystem

Info

Publication number
DE69737101D1
DE69737101D1 DE69737101T DE69737101T DE69737101D1 DE 69737101 D1 DE69737101 D1 DE 69737101D1 DE 69737101 T DE69737101 T DE 69737101T DE 69737101 T DE69737101 T DE 69737101T DE 69737101 D1 DE69737101 D1 DE 69737101D1
Authority
DE
Germany
Prior art keywords
cells
gentransfer
compositions
nervous system
producer cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69737101T
Other languages
English (en)
Other versions
DE69737101T2 (de
Inventor
Bruce Cherskey
R Bucalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Titan Pharmaceuticals Inc
New York University NYU
Original Assignee
Titan Pharmaceuticals Inc
New York University Langone Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Titan Pharmaceuticals Inc, New York University Langone Medical Center filed Critical Titan Pharmaceuticals Inc
Publication of DE69737101D1 publication Critical patent/DE69737101D1/de
Application granted granted Critical
Publication of DE69737101T2 publication Critical patent/DE69737101T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69737101T 1996-04-08 1997-04-07 Zusammensetzungen zur gentransfer in das zentrale nervensystem Expired - Fee Related DE69737101T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/629,308 US6210664B1 (en) 1996-04-08 1996-04-08 Method for gene transfer to the central nervous system
PCT/US1997/005746 WO1997037684A1 (en) 1996-04-08 1997-04-07 Method for gene transfer to the central nervous system
US629308 2003-07-29

Publications (2)

Publication Number Publication Date
DE69737101D1 true DE69737101D1 (de) 2007-01-25
DE69737101T2 DE69737101T2 (de) 2007-05-31

Family

ID=24522456

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737101T Expired - Fee Related DE69737101T2 (de) 1996-04-08 1997-04-07 Zusammensetzungen zur gentransfer in das zentrale nervensystem

Country Status (13)

Country Link
US (2) US6210664B1 (de)
EP (1) EP0927043B8 (de)
JP (2) JP2000508641A (de)
AT (1) ATE347903T1 (de)
AU (1) AU724537C (de)
CA (1) CA2251232C (de)
DE (1) DE69737101T2 (de)
DK (1) DK0927043T3 (de)
ES (1) ES2277356T3 (de)
PT (1) PT927043E (de)
TW (1) TWI222870B (de)
WO (1) WO1997037684A1 (de)
ZA (1) ZA972971B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210664B1 (en) * 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system
WO2007117440A2 (en) * 2006-03-30 2007-10-18 Research Foundation Of City University Of New York Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378576B1 (de) * 1987-09-11 1995-01-18 Whitehead Institute For Biomedical Research Transduktionsveränderte fibroblasten und ihre anwendung
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
ES2193132T3 (es) * 1990-10-19 2003-11-01 Univ New York Procedimiento para transplantar celulas en el cerebro y utilizaciones terapeuticas del mismo.
US5618531A (en) * 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5529774A (en) 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
JPH07503467A (ja) * 1992-01-23 1995-04-13 ニューヨーク ユニヴァーシティー 細胞を脳に移植する方法及びその治療使用
DE69431295T2 (de) * 1993-04-21 2003-05-15 Institut Pasteur, Paris Biokompatibles implantat zur in vivo expression und sekretion von therapeutischer verbindung
ATE218893T1 (de) * 1993-08-12 2002-06-15 Neurotech Sa Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
US6210664B1 (en) * 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system

Also Published As

Publication number Publication date
TWI222870B (en) 2004-11-01
ES2277356T3 (es) 2007-07-01
AU724537C (en) 2001-07-19
CA2251232A1 (en) 1997-10-16
US6565845B2 (en) 2003-05-20
DK0927043T3 (da) 2007-04-10
EP0927043B8 (de) 2007-04-18
HK1021801A1 (en) 2000-07-07
AU2444997A (en) 1997-10-29
US6210664B1 (en) 2001-04-03
JP2004337176A (ja) 2004-12-02
EP0927043A1 (de) 1999-07-07
DE69737101T2 (de) 2007-05-31
EP0927043B1 (de) 2006-12-13
ZA972971B (en) 1997-11-03
EP0927043A4 (de) 2004-09-01
WO1997037684A1 (en) 1997-10-16
CA2251232C (en) 2005-10-25
PT927043E (pt) 2007-03-30
US20010003585A1 (en) 2001-06-14
ATE347903T1 (de) 2007-01-15
AU724537B2 (en) 2000-09-21
JP2000508641A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
SE0201328L (sv) Hematopoietisk differentiering av humana embryonala stamceller
EP1007630A4 (de) Natürliche killerzelllinien und verfahren zu ihrer verwendung
DK0671923T3 (da) Leverreserveceller
Tiwari et al. Ex vivo expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS‐5 stromal cell line
DK0728194T3 (da) In situ modifikation og manipulation af stamceller fra centralnervesystemet.
CA2244659A1 (en) Biological reactor for the cultivation of cells
ATE368103T1 (de) Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems
GB2091271B (en) Recombinant dna
DK1019493T3 (da) Fremstilling af hæmatopoietiske celler fra multipotente neurale stamceller
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
US8927273B2 (en) Process for producing cytotoxic lymphocytes
DE69737101D1 (de) Zusammensetzungen zur gentransfer in das zentrale nervensystem
Medina et al. Isolation of epithelial stem cells from dermis by a three‐dimensional culture system
DE69624937D1 (de) Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen
Chan et al. Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells
ATE314461T1 (de) Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen
Racila et al. Are epidermal stem cells unique with respect to aging?
EP0765398A4 (de) Population von mit myeloid-und/oder lymphoid-vorläufern angereicherten zellen und verfahren zur ihrer gewinnung und verwendung
Cossu et al. Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts.
DE69737597D1 (de) Vektoren zur inhibierung von viralem und tumorwachstum
ATE384121T1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
Emmett Astroglial phenotype in vivo and in vitro.
Lilja Experimental studies on the effects of hepatocyte-based liver support.
ATE326526T1 (de) Verfahren zur herstellung von neuronalem zellmaterial
Pande Ex vivo expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS‐5 stromal cell line

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NEW YORK UNIVERSITY, NEW YORK, N.Y., US

Owner name: TITAN PHARMACEUTICALS, INC., SOMERVILLE, N.J., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee